Study to assess the tolerability and durable effect of AMG 145 in patients with Hyperlipidemia

Update Il y a 4 ans
Reference: EUCTR2011-003827-37

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To evaluate the effect of 52 weeks of subcutaneous (SC) AMG 145 monthly (QM), compared with placebo, on percent change from baseline in low-density lipoprotein cholesterol (LDL-C) when added to background lipid-lowering therapy


Inclusion criteria

  • Hyperlipidemia